tb 4 frag bpc 157 arg 700mcg BPC-157 + TB4-Frag TB4 and TB-500 Peptide Therapy
Description
PLOS ONE 7, e32366
Because they act through entirely different biological pathways, researchers often combine them for broader coverage of tissue-repair pathways in preclinical models than either peptide provides alone
Gavrilova SA, Golubeva AV, Lipina TV, Fominykh ES, Shornikova MV, Postnikov AB, Andrejeva LA, Chentsov IuS, Koshelev VB
Nasal Dosing Nasal GHK-Cu is the least-studied route, and the evidence is thin
Morb Mortal Wkly Rep
Can Med Assoc J (1980) 122:100713
